Pembrolizumab Prior to Surgery for Stage 1B, 2 or 3A Non-small Cell Lung Cancer (NSCLC): A Phase II Study

Administered By

Awarded By

Contributors

Start/End

  • July 1, 2020 - August 31, 2025